SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Exelixis, Inc. (EXEL) -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (165)6/13/2005 9:21:23 AM
From: rkrw  Read Replies (1) | Respond to of 930
 
It will all depend on what they're spending their money on.

I do expect gsk's two to come out of the three that are in Symphony.

$10? I'll take that bet. Open ended, that's not like you.

P.S. I officially won the Genta bet we made last year. Still waiting for my Blue Ginger lunch when celg buys enmd :-)



To: DewDiligence_on_SI who wrote (165)1/6/2006 10:48:46 AM
From: rkrw  Read Replies (1) | Respond to of 930
 
Took just under 7 months......

Message 21411105

So where are we going to eat?

Sorry couldn't help myself :-)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News